NasdaqCM - Nasdaq Real Time Price USD
Cassava Sciences, Inc. (SAVA)
1.5900
+0.1300
+(8.90%)
At close: 4:00:00 PM EDT
1.5598
-0.03
(-1.90%)
After hours: 7:00:31 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 50,000 | 1 |
| Sales | 65,800 | 2 |
| Net Shares Purchased (Sold) | -15,800 | 3 |
| Total Insider Shares Held | 6.18M | -- |
| % Net Shares Purchased (Sold) | -0.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SCHOEN ERIC J. Chief Financial Officer | Sale at price 3.82 - 3.86 per share. | Indirect | 238,468 | Nov 29, 2024 |
| KUPIEC JAMES WILLIAM Officer | Sale at price 3.87 per share. | Direct | 15,480 | Nov 29, 2024 |
| SCHOEN ERIC J. Chief Financial Officer | Conversion of Exercise of derivative security at price 1.18 per share. | Direct | 59,000 | Nov 29, 2024 |
| ROBERTSON SANFORD R Director | Stock Gift at price 0.00 per share. | Direct | 0 | May 16, 2024 |
| ROBERTSON SANFORD R Director | Conversion of Exercise of derivative security at price 22.00 per share. | Direct | 1,518,000 | Apr 26, 2024 |
| BARRY RICHARD J Director | Conversion of Exercise of derivative security at price 22.00 per share. | Indirect | 3,873,870 | Apr 23, 2024 |
| KUPIEC JAMES WILLIAM Officer | Conversion of Exercise of derivative security at price 22.00 per share. | Direct | 33,000 | Apr 18, 2024 |
| SCHOEN ERIC J. Chief Financial Officer | Conversion of Exercise of derivative security at price 22.00 per share. | Direct | 33,000 | Apr 17, 2024 |
| ROBERTSON SANFORD R Director | Purchase at price 17.45 per share. | Direct | 523,500 | Aug 23, 2023 |
| BARRY RICHARD J Director | Purchase at price 16.65 - 16.80 per share. | Indirect | 307,928 | Aug 22, 2023 |
| SCANNON PATRICK J M.D., PH.D. Director | Conversion of Exercise of derivative security at price 0.95 per share. | Direct | 950 | Jun 12, 2023 |
| BARBIER REMI Chief Executive Officer | Conversion of Exercise of derivative security at price 16.87 per share. | Indirect | 1,445,978 | May 24, 2023 |
| ROBERTSON SANFORD R Director | Conversion of Exercise of derivative security at price 16.66 - 19.60 per share. | Direct | 165,170 | May 10, 2023 |
| GUSSIN ROBERT Z Director | Conversion of Exercise of derivative security at price 16.66 - 19.60 per share. | Direct | 165,170 | May 1, 2023 |
Related Tickers
AVXL Anavex Life Sciences Corp.
9.21
+5.14%
ANVS Annovis Bio, Inc.
1.4700
+8.89%
NVAX Novavax, Inc.
6.25
+3.99%
MURA Mural Oncology plc
2.7200
+1.12%
OCGN Ocugen, Inc.
0.6875
+1.54%
IOVA Iovance Biotherapeutics, Inc.
3.2100
+4.22%
MIST Milestone Pharmaceuticals Inc.
1.0600
+4.95%
IBRX ImmunityBio, Inc.
2.6900
+7.17%
TNXP Tonix Pharmaceuticals Holding Corp.
14.96
0.00%
VKTX Viking Therapeutics, Inc.
25.48
+7.42%